Takeda Pharmaceutical Company Limited
$16.62
$0.06(-0.36%)
Takeda Pharmaceutical Company Limited
TAK
$16.62
$0.06(-0.36%)
Takeda Pharmaceutical Company Limited
TAK
NYSE
$16.62
$0.06(-0.36%)
Chart
Upcoming Earnings
Next report date
May 13, 2026
Report period
Q2 2026
EPS Estimate
$-0.08
Revenue Estimate
$7.17B
Key stats
52-Week Range$16.62
$12.99
$18.90
Market capitalization
$52.28BDividend yield (indicated)
3.82%Price to earnings Ratio (TTM)
73.28Basic EPS (TTM)
$36.74Net income (TTM)
$114.75BRevenue (TTM)
$4.49TAvg. volume
2.73MBeta (1Y)
0.13Employees
49.28KMarket capitalization
$52.28BDividend yield (indicated)
3.82%Price to earnings Ratio (TTM)
73.28Basic EPS (TTM)
$36.74Net income (TTM)
$114.75BRevenue (TTM)
$4.49TAvg. volume
2.73MBeta (1Y)
0.13Employees
49.28KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Takeda Pharmaceutical Company Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Christophe Weber
Website
www.takeda.comHeadquarters
1-1, Nihonbashi-Honcho 2-chome, Tokyo, 103-8668
IPO Date
2010-01-05
Identifiers
ISIN
US8740602052Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products...
Related Stocks
$144.17
1D:
-1.5%
1Y:
39.7%
US0758871091Healthcare
Mkt Cap
$52.23B
P/E Ratio TTM
24.2
Revenue TTM
$21.92B
Beta
0.35
Earnings TTM
$1.76B
Dividend Yield TTM
2.50%
$82.91
1D:
-0.5%
1Y:
10.4%
US28176E1082Healthcare
Mkt Cap
$47.80B
P/E Ratio TTM
44.5
Revenue TTM
$6.30B
Beta
0.95
Earnings TTM
$1.09B
Dividend Yield TTM
0.00%
Dividend Overview
Dividend yield (indicated)
3.82%
Dividend per share
$200.00annual
Payout ratio (Earnings)
2.8%
Payout ratio (FCF)
33.9%
Dividend growth streak
0
Dividend CAGR (3Y)
-22.0%
Dividend CAGR (5Y)
-18.0%
Dividend CAGR (10Y)
-9.7%
Dividend yield (indicated)
3.82%
Dividend per share
$200.00annual
Payout ratio (Earnings)
2.8%
Payout ratio (FCF)
33.9%
Dividend growth streak
0
Dividend CAGR (3Y)
-22.0%
Dividend CAGR (5Y)
-18.0%
Dividend CAGR (10Y)
-9.7%
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate